1 October 2019News

Sompo expands partnership with Pharm3r in US life sciences

Sompo International Holdings has expanded its strategic partnership with Pharm3r, a life science and healthcare data analytics company, in a move it said will enhance its US life sciences risk modeling capabilities.

The agreement means Sompo’s global risk solutions (GRS) life sciences team is now using Pharm3r’s data sets and analytics. Sompo said it gives clients and brokers faster turnaround times, while enhancing the team’s risk modeling capabilities.

Bermuda-based Sompo is specialty provider of property and casualty re/insurance. Sompo GRS works through a network of retail brokers to offer comprehensive multi-line capabilities targeted to accounts in select industry verticals, including life sciences, real estate, hospitality, financial institutions and professional services.

Todd Lauer, senior vice president and leader of the Sompo GRS life sciences team said: “Our partnership with Pharm3r will provide our life sciences team with an expanded data set, strengthening our ability to assess and service each account. The ability to combine our expertise in the life sciences industry with Pharm3r’s state-of-the-art analytics will enhance the white glove service we deliver to our clients.”




More on this story

News
25 October 2019   Sompo International is expanding its capabilities in Mexico with the addition of a new Sompo International global risk solutions (GRS) team that will focus on serving clients in select industry verticals.

More on this story

News
25 October 2019   Sompo International is expanding its capabilities in Mexico with the addition of a new Sompo International global risk solutions (GRS) team that will focus on serving clients in select industry verticals.